BS PHARM KOREA successfully concluded its participation in Dubai Derma 2026, held from September 8–10 in Dubai.

Throughout the exhibition, our team met with doctors and distributors from the UAE, the wider Middle East, Europe, CIS, and other international markets.

The event provided a valuable opportunity to introduce our professional aesthetic portfolio, discuss distribution opportunities, and better understand current product interests across global markets.

Skin boosters emerged as one of the most discussed product categories at our booth.

In particular, visitors showed strong interest in HA skin boosters, along with formulations based on PDRN, NAD+, and exosome-related concepts.

▶ Dubai Derma 2026 Showed Strong Interest in Skin Boosters

At the BS PHARM KOREA booth, skin boosters attracted stronger attention than traditional fillers.

Many visitors were interested in products focused on hydration, skin quality, and regenerative aesthetics, rather than volume correction alone.

This interest was especially visible in conversations around HA-based skin boosters. At the same time, ingredient-driven products featuring PDRN, NAD+, and exosome-related concepts also generated frequent inquiries.

While this reflects our booth experience rather than a formal market survey, the response offered useful insight into the product categories drawing attention from international aesthetic professionals.

▶ HA Skin Boosters Attracted Particular Attention

Among the products presented at Dubai Derma 2026, INHILO+ and EVENEX generated strong interest as HA-based skin booster solutions.

▶ INHILO+: Dual HA, Distribution, and Certification

INHILO+ was one of the most discussed products at our booth.

Visitors frequently asked about its Dual HA concept and how the formulation differs from other HA-based skin booster approaches.

Distributor conversations also focused on distribution opportunities and certification status.

These discussions showed that market interest extended beyond formulation alone. Commercial readiness and market entry potential were also important considerations.

▶ EVENEX: Formulation, Pricing, and Market Positioning

EVENEX also attracted attention from visitors comparing HA skin booster options.

Questions mainly focused on its ingredient composition, pricing, and product positioning.

This reflected a practical buying perspective. Visitors were not only comparing formulations, but also evaluating commercial suitability within their local markets.

▶ Regenerative Aesthetics: Interest in PDRN, NAD+, and Exosome-Based Concepts

In addition to HA skin boosters, visitors frequently asked about products based on PDRN, NAD+, and exosome-related formulations.

This interest was reflected in conversations around NA:DRN and EXOGEN.

▶ NA:DRN drew interest for its NAD+ and PDRN formulation.

NA:DRN generated interest for its combination of NAD+ and PDRN

Visitors asked about the formulation concept and how the product could be positioned within a professional skin booster portfolio.

These discussions reflected broader interest in ingredient-driven solutions associated with skin quality and regenerative aesthetics.

▶ EXOGEN drew interest for its exosome-based concept

EXOGEN also received inquiries from visitors interested in exosome-based aesthetic solutions.

Discussions focused on the product concept and how exosome-related formulations could fit within broader regenerative skin booster categories.

Together, the response to NA:DRN and EXOGEN showed that many visitors were looking beyond conventional HA products and exploring a wider range of skin quality-focused ingredients.

▶ Dubai Derma 2026 Scientific Program Reflected Similar Trends

The Dubai Derma 2026 scientific program also featured topics related to skin boosters, regenerative medicine, exosomes, PDRN, and biostimulation.

Sessions addressed areas such as polynucleotides, skin boosters, collagen biostimulators, regenerative medicine, and combined approaches using exosomes and PDRN.

These academic topics were consistent with many of the product questions and discussions we experienced at our booth.

▶ Distribution Opportunities and Follow-Up Meetings

Dubai Derma 2026 also provided valuable opportunities for business development.

Our team held discussions with doctors and distributors from several international markets. Many conversations focused on distribution opportunities, certification, pricing, market positioning, and local market suitability.

Some of these discussions continued into follow-up meetings after the exhibition.

For BS PHARM KOREA, these conversations provided useful insights into how different markets evaluate skin booster products and which product concepts are receiving greater attention.

▶ What We Learned at Dubai Derma 2026

Several clear themes stood out during the exhibition.

First, skin boosters generated stronger interest than traditional filler products at our booth.

Second, HA skin boosters remained a key area of interest especially when products offered differentiated formulation concepts.

Third, visitors also showed clear interest in PDRN, NAD+, and exosome-related formulations.

Finally, distributor discussions confirmed that market interest goes beyond product formulation. Certification, pricing, positioning, and distribution strategy also play an important role in product evaluation.

▶ Looking Ahead After Dubai Derma 2026

BS PHARM KOREA would like to thank everyone who visited our booth during Dubai Derma 2026.

The exhibition provided an important opportunity to introduce our portfolio, understand current market interests, and strengthen relationships with international professionals and potential partners.

The strong response to INHILO+, NA:DRN, EXOGEN, and EVENEX also provided valuable feedback on the growing interest in skin booster and regenerative aesthetic categories.

Following Dubai Derma 2026, BS PHARM KOREA will continue to expand its global network and develop new opportunities for international distribution and collaboration.

Our upcoming international exhibitions include:

• – INTERCHARM Moscow — October 14–16, 2026
• – AMWC Dubai — October 21–23, 2026
• – AMWC Latin America — October 29–31, 2026

We look forward to meeting more partners at these upcoming exhibitions and continuing discussions around skin quality, regenerative aesthetics, distribution opportunities, and professional aesthetic solutions.